PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: American Science and Technology

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

American Science and Technology Awarded Second New Patent - New Patented Process Can Produce High Quality Pulp As Well As Desirable Bio-Renewable Materials - AmSnT.com
American Science and Technology Awarded Second New Patent

 

NewswireToday - /newswire/ - Chicago, IL, United States, 2016/09/27 - New Patented Process Can Produce High Quality Pulp As Well As Desirable Bio-Renewable Materials - AmSnT.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

American Science and Technology (AST), a sustainable technology company focused on providing R&D services to develop innovative processes that can produce cost-competitive renewable chemicals and materials from non-food biomass, has won a second patent (US 9,382, 283 B2) in as many months, related to its Organosolv pulping process. The new patent covers a system and method for oxygen-assisted delignification of lignocellulosic biomaterials and lignin recovery, which further improves the quality of the pulp produced by the AST Organosolv pulping process.

AST scientists successfully developed a new combination of Organosolv solvents and processes that can produce high purity lignin, bio renewable chemicals, and high quality pulp. The patented process delignifies the lignocellulosic biomass by dissolving lignin in organic solvent and converts most of the hemicellulose to biochemicals (such as furfural, butyl acetate, etc.). At the end of the process, high quality pulp is produced by taking advantage of a novel combination of oxidants. AST’s Organosolv-based pulp has been successfully tested for paper production as well as for high quality cellulosic sugar production. AST’s lignin, with high purity, has been used for various applications such as bio-renewable polymers, bio-renewable colorants for polymers, and as a base for composite materials.

“Traditionally, the pulping industry has considered pulp as the end product of their processes and the only value to the remaining lignin was for burning as a low energy density fuel,” said AST President and CEO, Dr. Ali Manesh. “The new processes developed and tested by AST, produce pulp, bio renewable chemicals, and pure lignin. Since the bio renewable chemicals and high purity lignin are more valuable than the remaining pulp, the overall pulping process can become much more profitable.”

American Science and Technology’s bio-refinery pilot plant, with a 2 ton per day processing capacity, is available to industry to provide process and product development support. Currently, AST’s facilities are being used by clients and strategic partners from a wide range of industries, including two Fortune 500 companies, to develop sustainable and economically viable processes to convert non-food cellulosic biomass into highly refined fermentable sugars, high purity lignin, high quality pulp, and organic solvents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: American Science and Technology

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


American Science and Technology Awarded Second New Patent

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Ali Manesh - AmSnT.com 
312-433-3800 jr[.]amsnt.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any American Science and Technology securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From American Science and Technology / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  S&A Capital Partner Ltd

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)